top of page

Research

Dr. O’Reilly and the research team at the University of Limerick are conducting a survey of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis survivors.

Their research involves two rounds of surveys aiming to developing a Quality of Life (QoL) outcome measure specific for SJS/TEN patients. Existing general QoL outcome measures do not capture the specific experiences of SJS/TEN survivors; this tool may help more clinicians assess SJS/TEN survivors’ quality of life and identify areas of improvement.

​

How to find out more and participate

If you would like to learn more about the study or are interested in participating, please contact Professor Pauline O’Reilly at the Department of Nursing and Midwifery, University of Limerick.


You can reach her via email at Pauline.OReilly@ul.ie.

Workspace

Know more about the research

STUDIES ON GENETICS

A research titled: – STUDIES ON GENETICS conducted by:

​

Dr. Bruce Carleton
Chair, Division of Translational Therapeutics
Faculty of Medicine
University of British Columbia

​

As per Dr. Carleton, the central theme of his research program, Pharmaceutical Outcomes and Policy Innovations (POPi), is the study of drug therapy with the goal of improving human health and quality of life.

​

He is interested in developing models for evaluating drug effectiveness, medication use models designed to improve patient health, and effective surveillance systems to improve the safe use of medication. He also has an interest in the clinical management of patients who experience serious adverse drug reactions.

​

You can learn more about Dr. Carleton’s research program by emailing him at the email address listed below.

FOR DETAILS ABOUT THIS RESEARCH PROJECT:

​

Please email: bcarleton@popi.ubc.ca

​

Survivors and family members of Stevens-Johnson Syndrome & Toxic Epidermal Necrolysis are encouraged to get involved

bottom of page